Follow Us      

LOGIN
 
Share Page:
Back

Volume 25 , Issue 2
March/April 2005

Pages 129137


Clinical Case Reports of Injectable Tissue-Engineered Bone for Alveolar Augmentation with Simultaneous Implant Placement

Minoru Ueda, DDS, PhD/Yoichi Yamada, DDS, PhD/Ryotaro Ozawa, DDS/Yasuhiro Okazaki, DDS, PhD


PMID: 15839589
DOI: 10.11607/prd.00.0630

This clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height. All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success. (Int J Periodontics Restorative Dent 2005;25:129137.)


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2014 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Accepted Manuscripts
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help